US4617279A - Calcium phosphate type crystallizable glass - Google Patents

Calcium phosphate type crystallizable glass Download PDF

Info

Publication number
US4617279A
US4617279A US06/775,355 US77535585A US4617279A US 4617279 A US4617279 A US 4617279A US 77535585 A US77535585 A US 77535585A US 4617279 A US4617279 A US 4617279A
Authority
US
United States
Prior art keywords
mol
glass
calcium phosphate
phosphate type
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
US06/775,355
Inventor
Tsuneo Manabe
Shigeyoshi Kobayashi
Hitoshi Kijimuta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AGC Inc
Original Assignee
Asahi Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Glass Co Ltd filed Critical Asahi Glass Co Ltd
Assigned to ASAHI GLASS COMPANY, LTD. reassignment ASAHI GLASS COMPANY, LTD. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: KIJIMUTA, HITOSHI, KOBAYASHI, SHIGEYOSHI, MANABE, TSUNEO
Application granted granted Critical
Publication of US4617279A publication Critical patent/US4617279A/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/02Inorganic materials
    • A61L27/12Phosphorus-containing materials, e.g. apatite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/70Preparations for dentistry comprising inorganic additives
    • A61K6/78Pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/836Glass
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K6/00Preparations for dentistry
    • A61K6/80Preparations for artificial teeth, for filling teeth or for capping teeth
    • A61K6/831Preparations for artificial teeth, for filling teeth or for capping teeth comprising non-metallic elements or compounds thereof, e.g. carbon
    • A61K6/838Phosphorus compounds, e.g. apatite
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C10/00Devitrified glass ceramics, i.e. glass ceramics having a crystalline phase dispersed in a glassy phase and constituting at least 50% by weight of the total composition
    • CCHEMISTRY; METALLURGY
    • C03GLASS; MINERAL OR SLAG WOOL
    • C03CCHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MATERIALS
    • C03C3/00Glass compositions
    • C03C3/12Silica-free oxide glass compositions
    • C03C3/16Silica-free oxide glass compositions containing phosphorus
    • C03C3/17Silica-free oxide glass compositions containing phosphorus containing aluminium or beryllium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005The prosthesis being constructed from a particular material
    • A61F2310/00179Ceramics or ceramic-like structures
    • A61F2310/00293Ceramics or ceramic-like structures containing a phosphorus-containing compound, e.g. apatite

Definitions

  • the present invention relates to calcium phosphate type crystallizable glass for dental materials, and calcium phosphate type crystallized glass obtained therefrom. More particularly, the present invention relates to calcium phosphate type crystallizable glass, from which highly strong, highly water resistant, translucent crystallized glass having a milky white color or a color and color tone resembling those of natural teeth is obtainable which is suitable for use as dental materials such as artificial teeth, crowns, inlays or bridges.
  • This calcium phosphate type crystallized glass has a composition similar to that of natural teeth or natural bones, and its physical, chemical and mechanical properties are close to those of natural teeth and natural bones. Thus, it has good compatibility with living bodies. Yet, it can be prepared by a simple process such that a starting material is melted and poured into a mold, like a glass, to obtain a molded product having a desired shape, followed by crystallization. Further, the shrinkage during the process for its preparation is as small as at most 1%, and fine processing is not required even for a complicated configuration. Thus, it is expected to be a prospective material having superior properties and high productivity as compared with the conventional metallic materials or ceramic materials, as dental materials or ceramic materials for living bodies such as bones for surgery.
  • a number of pores having a diameter of about 1 ⁇ m are present in the glass crystallized structure, and the crystallized glass is white and opaque and thus presents an outer appearance which is different from natural teeth.
  • the present invention provides calcium phosphate type crystallizable glass for dental materials, which is composed essentially of from 41 to 49.5 mol % of CaO, from 50 to 58.5 mol % of P 2 O 5 and from 0.5 to 5 mol % of Al 2 O 3 , and which has an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.35 to 0.49.
  • the present invention provides also calcium phosphate type crystallized glass prepared by crystallizing the above calcium phosphate type crystallizable glass.
  • FIG. 1 is a graph showing the relation between the atomic ratio of Ca/P and the bending strength of the calcium phosphate type crystallized glass obtained by the present invention.
  • the "crystallizable glass” means glass which has not yet been subjected to crystallization treatment
  • the "crystallized glass” means glass which has been treated for crystallization
  • Calcium phosphate type crystallizable glass to be used in the present invention is composed of calcium metaphosphate (CaO.P 2 O 5 ) having a chain structure whether it is in a vitrified state or in a crystallized state, and should have an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.35 to 0.49 so that the glass has a proper melting point and melt viscosity for efficient casting, and the crystallized glass will have adequate strength and water resistance.
  • the calcium phosphate type crystallizable glass as the base material most suitably has a composition comprising from 41.0 to 49.5 mol % of CaO and from 50.5 to 59.0 mol % of P 2 O 5 .
  • the CaO content is less than 41 mol %, or if the P 2 O 5 content exceeds 58.5 mol %, crystallization hardly takes place, it will be difficult to obtain crystallized glass having a uniform quality, and the water resistance will be extremely low since the vitrified phase between crystal particles contains P 2 O 5 in a high concentration.
  • the melt thereby obtained is poured into a mold having a desired shape of the dental material to form a molded product having the desired shape, followed by crystallization to obtain the final product.
  • An investment mold is preliminarily made by the lost-wax method. That is, a wax pattern having desired shape is sprued and invested and, after the investment has set, the investment mold is heated to remove the wax pattern by burning and then maintained at a temperature of from 500° to 800° C.
  • the melt of calcium phosphate type crystallizable glass thus obtained is cast and molded in that investment mold.
  • the molded product is then taken out together with the embedding material or from the embedding material, and subjected to crystallization treatment to obtain a final product.
  • mol % from 0.001 to 1% by weight
  • at least one element selected from the group consisting of Ru, Rh and Pd may be incorporated to impart the color as well as the color tone resembling natural teeth.
  • Ru, Rh or Pd may be incorporated in the molten glass material in the form of elemental metal, an oxide, a hydroxide, a halide, a sulfide, a nitrate, a sulfate or an organic salt.

Abstract

Calcium phosphate type crystallizable glass for dental materials, which is composed essentially of from 41 to 49.5 mol % of CaO, from 50 to 58.5 mol % of P2 O5 and from 0.5 to 5 mol % of Al2 O3, and which has an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.35 to 0.49.

Description

The present invention relates to calcium phosphate type crystallizable glass for dental materials, and calcium phosphate type crystallized glass obtained therefrom. More particularly, the present invention relates to calcium phosphate type crystallizable glass, from which highly strong, highly water resistant, translucent crystallized glass having a milky white color or a color and color tone resembling those of natural teeth is obtainable which is suitable for use as dental materials such as artificial teeth, crowns, inlays or bridges.
As dental materials such as artificial teeth, artificial roots of teeth, crowns, inlays or bridges, or as ceramic materials for living bodies such as artificial bones for surgery, there has been proposed, e.g. in Japanese Examined Patent Publication No. 11625/1980, calcium phosphate type crystallized glass having a crystallinity of at least 20%, which is obtained by melting and molding a glass composed of from 28 to 57% by weight of CaO and from 72 to 43% by weight of P2 O5, or such a glass containing at most 10% by weight of Al2 O3, SiO2 or B2 O3, followed by heat treatment.
This calcium phosphate type crystallized glass has a composition similar to that of natural teeth or natural bones, and its physical, chemical and mechanical properties are close to those of natural teeth and natural bones. Thus, it has good compatibility with living bodies. Yet, it can be prepared by a simple process such that a starting material is melted and poured into a mold, like a glass, to obtain a molded product having a desired shape, followed by crystallization. Further, the shrinkage during the process for its preparation is as small as at most 1%, and fine processing is not required even for a complicated configuration. Thus, it is expected to be a prospective material having superior properties and high productivity as compared with the conventional metallic materials or ceramic materials, as dental materials or ceramic materials for living bodies such as bones for surgery.
Further, a process for the production of calcium phosphate type crystallized glass suitable for use as a restorative material, is proposed in Japanese Unexamined Patent Publication No. 141508/1984 or No. 141509/1984, or in "COMMUNICATIONS OF AMERICAN CERAMIC SOCIETY" C-100(1984).
However, such conventional calcium phosphate type crystallized glass had the following practical problems.
(1) Cracks are likely to form during crystallization, and crystallized glass having adequate strength for practical use is hardly obtainable.
(2) A number of pores having a diameter of about 1 μm are present in the glass crystallized structure, and the crystallized glass is white and opaque and thus presents an outer appearance which is different from natural teeth.
(3) The deterioration of the strength in water is substantial, and it is not durable for use in a mouth.
It is an object of the present invention to solve the above-mentioned problems, and to provide calcium phosphate type crystallizable glass for dental materials, from which highly strong, highly water resistant calcium phosphate type crystallized glass having a translucent outer appearance is obtainable.
The present invention provides calcium phosphate type crystallizable glass for dental materials, which is composed essentially of from 41 to 49.5 mol % of CaO, from 50 to 58.5 mol % of P2 O5 and from 0.5 to 5 mol % of Al2 O3, and which has an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.35 to 0.49.
The present invention provides also calcium phosphate type crystallized glass prepared by crystallizing the above calcium phosphate type crystallizable glass.
Now, the present invention will be described in detail with reference to the preferred embodiments.
In the accompanying drawing, FIG. 1 is a graph showing the relation between the atomic ratio of Ca/P and the bending strength of the calcium phosphate type crystallized glass obtained by the present invention.
For the purpose of the present invention, the "crystallizable glass" means glass which has not yet been subjected to crystallization treatment, and the "crystallized glass" means glass which has been treated for crystallization.
Calcium phosphate type crystallizable glass to be used in the present invention, is composed of calcium metaphosphate (CaO.P2 O5) having a chain structure whether it is in a vitrified state or in a crystallized state, and should have an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.35 to 0.49 so that the glass has a proper melting point and melt viscosity for efficient casting, and the crystallized glass will have adequate strength and water resistance. Namely, the calcium phosphate type crystallizable glass as the base material most suitably has a composition comprising from 41.0 to 49.5 mol % of CaO and from 50.5 to 59.0 mol % of P2 O5.
In the present invention, the water resistance is evaluated primarily on the basis of the outer appearance and bending strength after soaking in distilled water.
If the ratio of Ca/P exceeds 0.49, it is difficult to obtain crystallized glass having adequate bending strength, such being undesirable. On the other hand, if the ratio is lower than 0.35, crystallization hardly takes place, and it becomes difficult to obtain uniformly crystallized glass, and at the same time the phosphorus component becomes excessive, whereby water resistance deteriorates.
Such calcium phosphate type crystallizable glass has a composition similar to that of natural teeth or bones, which are composed mainly of calcium phosphate materials, and which have an atomic ratio of calcium to phosphorus (Ca/P) within a range of from about 1.75 to about 2.0. Thus, it has good affinity with living bodies. With glass having such a composition, it is possible to obtain an artificial dental product having a desired shape by a simple process comprising melting the glass material and pouring it into a mold, followed by crystallization.
In the present invention, Al2 O3 is added to the calcium phosphate type crystallizable glass having the above base composition, in an amount of from 0.5 to 5 mol % relative to the calcium phosphate type crystallizable glass, in order to improve the water resistance of the glass and the crystallized glass. If the amount of Al2 O3 exceeds 5 mol %, the crystallizable glass tends to be brittle, and cracks are likely to form during the crystallization, whereby it is difficult to obtain highly strong crystallized glass. On the other hand, if the amount is less than 0.5 mol %, no adequate effect for the improvement of the water resistance will be obtained.
The calcium phosphate type crystallizable glass containing Al2 O3 according to the present invention has the following composition:
CaO: 41-49.5 mol % (21-28 wt %)
P2 O5 : 50-58.5 mol % (71-78 wt %)
Al2 O3 : 0.5-5 mol % (1-5 wt %)
If the CaO content exceeds 49.5 mol % or if the P2 O5 content is less than 50 mol %, the proportion of crystals in the crystallized glass tends to be too high when the above-mentioned calcium phosphate type crystallizable glass was crystallized. Consequently, the crystallized glass will be brittle, and cracks are likely to form during the crystallization, whereby it will be difficult to obtain highly strong crystallized glass. Further, a number of pores having a diameter of about 1 μm are likely to form during the crystallization, and the crystallized glass will be white and opaque, such being undesirable. On the other hand, if the CaO content is less than 41 mol %, or if the P2 O5 content exceeds 58.5 mol %, crystallization hardly takes place, it will be difficult to obtain crystallized glass having a uniform quality, and the water resistance will be extremely low since the vitrified phase between crystal particles contains P2 O5 in a high concentration.
Further, if the Al2 O3 content is less than 0.5 mol %, the amount of Al2 O3 to chemically stabilize P2 O5 in the vetrified phase between crystal particles in the crystallized glass and to prevent the elusion of P2 O5 into water, is too small, and the water resistance will be very low. On the other hand, if the Al2 O3 content exceeds 5 mol %, the crystallized glass tends to be brittle, and cracks are likely to form during the crystallization, whereby it will be difficult to obtain crystallized glass having high strength.
Within the above-mentioned ranges of the components of the crystallizable glass composition of the present invention, it is particularly preferred to employ the following composition:
CaO: 42-44 mol %
P2 O5 : 53-55 mol %
Al2 O3 : 2-4 mol %
and an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.38 to 0.42, whereby it will be possible to obtain highly durable crystallized glass having superior bending strength and water resistance.
As raw materials for the production of calcium phosphate type crystallizable glass of the present invention, CaO or a calcium compound capable of being converted to CaO, P2 O5 or a phosphorus compound capable of being converted to P2 O5 and Al2 O3 or an aluminum compound capable of being converted to Al2 O3, are mixed and, if necessary, formed into a slurry, then dried and pulverized to obtain calcium phosphate powder containing Al2 O3, which is then melted.
For the preparation of a dental product from this calcium phosphate type crystallizable glass, the melt thereby obtained is poured into a mold having a desired shape of the dental material to form a molded product having the desired shape, followed by crystallization to obtain the final product.
As the calcium compound, calcium carbonate and calcium oxide are the most typical representatives. However, other inorganic salts or organic salts of calcium such as calcium hydroxide, calcium hydrogencarbonate, calcium oxalate or calcium acetate, may be also employed.
As the phosphorus compound, there may be mentioned a phosphoric acid such as orthophosphoric acid, or an ammonium phosphate.
Further, a calcium salt of a phosphoric acid such as calcium phosphate, calcium hydrogenphosphate, calcium dihydrogenphosphate, calcium pyrophosphate, calcium polyphosphate or hydroxyapatite, may be used alone or in combination with other calcium compounds or phosphorus compounds.
As the aluminum compound, there may be employed aluminum hydroxide, aluminum oxide or aluminum nitrate.
More specifically, as an example for the preparation of the above-mentioned calcium phosphate type crystallizable glass dental material, from 26 to 34% by weight of finely pulverized CaCO3, from 73 to 66% by weight of H3 PO4 and from 0.5 to 5% by weight of Al(OH)3 are thoroughly mixed, water is added thereto to obtain a slurry, the slurry is dried and pulverized to obtain calcium phosphate powder containing an aluminum component, and the powder is baked at a temperature of from 200° to 900° C. for 1 to 10 hours to obtain a glass material. Then, a necessary amount of this glass material is put in a platinum crucible and heated and melted at a temperature of from 900° to 1500° C. for from 5 minutes to 10 hours to obtain a uniformly vitrified glass. An investment mold is preliminarily made by the lost-wax method. That is, a wax pattern having desired shape is sprued and invested and, after the investment has set, the investment mold is heated to remove the wax pattern by burning and then maintained at a temperature of from 500° to 800° C.
The melt of calcium phosphate type crystallizable glass thus obtained is cast and molded in that investment mold. The molded product is then taken out together with the embedding material or from the embedding material, and subjected to crystallization treatment to obtain a final product.
There is no particular restriction in the manner for crystallizing the molded glass product. For instance, it is possible to employ a method wherein the molded product is held in an atmosphere of from 500° to 900° C. for from 5 minutes to 100 hours. By such crystallizing treatment, it is possible to obtain calcium phosphate type crystallized glass having a crystallinity of at least 20%.
In addition to Al2 O3, a certain amount of other additives may be incorporated.
Further, in the present invention, from 0.001 to 1 mol % (from 0.001 to 1% by weight) of at least one element selected from the group consisting of Ru, Rh and Pd may be incorporated to impart the color as well as the color tone resembling natural teeth. Ru, Rh or Pd may be incorporated in the molten glass material in the form of elemental metal, an oxide, a hydroxide, a halide, a sulfide, a nitrate, a sulfate or an organic salt.
Now, the present invention will be described in further detail with reference to Examples. However, it should be understood that the present invention is by no means restricted to these specific Examples.
EXAMPLE 1
CaCO3 powder corresponding to 46 mol % (25% by weight) of CaO was mixed with Al(OH)3 powder corresponding to 1 mol % (1% by weight) of Al2 O3. To this mixture, phosphoric acid containing H3 PO4 corresponding to 53 mol % (74% by weight) of P2 O5 was dropwise added. The reaction product thereby obtained was dried and pulverized. The powder thereby obtained was baked at 400° C. for 5 hours. The baked product was melted in a platinum crucible at a temperature of 1250° C. under stirring for 2 hours, and then poured on a graphite plate and gradually cooled.
Calcium phosphate type crystallizable glass having a Ca/P ratio of 0.43 thus obtained, was milled into a rod having a square cross section of 2×2 mm and a length of 50 mm, and the rod was treated at 630° C. for 20 hours for crystallization. With respect to the crystallized glass thereby obtained, the properties such as the bending strength, etc. were measured. The results are shown in Table 1.
EXAMPLE 2
CaH4 (PO4)2.H2 O powder corresponding to 45 mol % (25% by weight) of CaO was mixed with Al(OH)3 powder corresponding to 2 mol % (2% by weight) of Al2 O3. To the mixture, phosphoric acid containing H3 PO4 corresponding to 8 mol % (11% by weight) of P2 O5, was dropwise added. The reaction product thereby obtained was dried and melted in a platinum crucible at a temperature of 1250° C. under stirring for 2 hours, and then poured onto an iron plate and gradually cooled to obtain a glass block.
A necessary amount of calcium phosphate type glass having an atomic ratio of Ca/P of 0.425 was cut out from the glass block, and melted in a platinum crucible at 1200° C. Then, the melt was cast and molded in an investment mold preliminarily prepared by a lost-wax method by the use of phosphate bonded investment to have a desired shape and then maintained at a temperature of 600° C., by a centrifugal casting method. The molded product was maintained together with the embedding material at a temperature of 650° C. for 10 hours for crystallizing treatment, whereby a cast crown made of crystallized glass was obtained. The properties of the crystallized glass thus obtained are shown in Table 1.
COMPARATIVE EXAMPLE 1
CaCO3, Al(OH)3 and H3 PO4 were mixed in such amounts that correspond to 52 mol % (30% by weight) of CaO, 1 mol % (1% by weight) of Al2 O3 and 47 mol % (69% by weight) of P2 O5, respectively. The mixture was treated in the same manner as in Example 1 to obtain calcium phosphate type crystallizable glass. This glass was subjected to crystallizing treatment at 630° C. for 20 hours. The properties of the crystallized glass having an atomic ratio of Ca/P of 0.55 thus obtained, are shown in Table 1.
COMPARATIVE EXAMPLE 2
CaCO3 and H3 PO4 were mixed in such amounts that correspond to 47 mol % (26% by weight) of CaO and 53 mol % (74% by weight) of P2 O5, respectively. The mixture was treated in the same manner as in Example 1 to obtain calcium phosphate type crystallizable glass. The glass was subjected to crystallizing treatment at 650° C. for 20 hours. The properties of the crystallized glass having an atomic ratio of Ca/P of 0.44 thereby obtained, are shown in Table 1.
                                  TABLE 1                                 
__________________________________________________________________________
                           Comparative                                    
                                  Comparative                             
               Example 1                                                  
                     Example 2                                            
                           Example 1                                      
                                  Example 2                               
__________________________________________________________________________
Vickers hardness                                                          
                390   400  380    380                                     
Compressive strength (kg/cm.sup.2)                                        
               5800  6200  3900   3700                                    
Bending strength (kg/cm.sup.2)                                            
               1580  1430  580    870                                     
Density (g/cm.sup.3)                                                      
               2.8   2.8   2.7    2.7                                     
Bending strength after                                                    
               1430  1400  380    160                                     
soaking in distilled water at                                             
37° C. for one week (kg/cm.sup.2)                                  
Outer appearance                                                          
               Translucency resembling                                    
                           Opaque Opaque                                  
               natural teeth                                              
__________________________________________________________________________
EXAMPLE 3
In the same manner as in Example 1, samples of calcium phosphate type crystallized glass having a composition as identified in Table 2, were prepared. With respect to these samples, the bending strength was measured. The relation between the Ca/P ratio and the bending strength of these glass samples was presented in the graph of FIG. 1.
The data of samples 1a to 1g were plotted to form curve A, the data of samples 2a to 2f were plotted to form curve B, the data of samples 3a to 3f were plotted to form curve C, and the data of samples 4a to 4d were plotted to form curve D, in FIG. 1.
These samples were found to have adequate bending strength and high water resistance.
              TABLE 2                                                     
______________________________________                                    
        CaO      P.sub.2 O.sub.5                                          
                          Al.sub.2 O.sub.3                                
                                 Ca/P                                     
Sample No.                                                                
        (mol %)  (mol %)  (mol %)                                         
                                 (Atomic ratio)                           
______________________________________                                    
1-a     42       57       1      0.37                                     
1-b     44       55       1      0.40                                     
1-c     45       54       1      0.42                                     
1-d     46       53       1      0.43                                     
1-e     47       52       1      0.45                                     
1-f     48       51       1      0.47                                     
1-g     50       49       1      0.51                                     
2-a     41       57       2      0.36                                     
2-b     42       56       2      0.38                                     
2-c     43       55       2      0.39                                     
2-d     44       54       2      0.41                                     
2-e     45       53       2      0.42                                     
2-f     46       52       2      0.44                                     
3-a     40       57       3      0.35                                     
3-b     41       56       3      0.37                                     
3-c     42       55       3      0.38                                     
3-d     43       54       3      0.40                                     
3-e     44       53       3      0.42                                     
3-f     45       52       3      0.43                                     
4-a     40       56       4      0.36                                     
4-b     41       55       4      0.37                                     
4-c     42       54       4      0.39                                     
4-d     43       53       4      0.41                                     
______________________________________                                    
EXAMPLE 4
In the same manner as in Example 1, samples of calcium phosphate type crystallized glass having a composition as identified in Table 3, were prepared. With respect to these samples, the bending strength was measured. The results are shown in Table 3.
                                  TABLE 3                                 
__________________________________________________________________________
                           Bending strength                               
                                    Bending strength                      
                                             Bending strength             
                                                      Outer appearance    
                           after soaking in                               
                                    after soaking in                      
                                             after soaking                
                                                      after soaking in    
       CaO                                                                
          P.sub.2 O.sub.5                                                 
             Al.sub.2 O.sub.3                                             
                 Ca/P Bending                                             
                           distilled water                                
                                    distilled water                       
                                             distilled water              
                                                      distilled water     
       (mol                                                               
          (mol                                                            
             (mol                                                         
                 (Atomic                                                  
                      strength                                            
                           at 37° C. for 1                         
                                    at 80° C. for                  
                                             at 80° C. for         
                                                      at 80° C.    
                                                      for 20              
Sample No.                                                                
       %) %) %)  ratio)                                                   
                      (kg/cm.sup.2)                                       
                           month (kg/cm.sup.2)                            
                                    days (kg/cm.sup.2)                    
                                             days (kg/cm.sup.2)           
                                                      days*               
__________________________________________________________________________
E      47 53 0   0.43  800 <100     <100     Collapsed                    
                                                      Collapsed           
(Comparative                                 during soaking               
                                                      material was        
example)                                              white and opaque    
F      46 53 1   0.43 2010 1430      850     <100     White and opaque    
(Example)                                                                 
G      44 54 2   0.41 1920 1850     1620     650      Slightly opaque     
(Example)                                             only at the         
                                                      surface             
H      43 54 3   0.40 1730 1710     1720     1710     No change           
(Example)                                                                 
J      41 55 4   0.37 1320 1300     1230     850      No change           
(Example)                                                                 
K      40 55 5   0.36  850  850      630     310      Partially opaque    
(Example)                                                                 
__________________________________________________________________________
 *Prior to soaking, Samples E to K were all translucent.                  
EXAMPLE 5
Crystallized glass was prepared from Sample H (Table 3) glass in Example 4 in the same manner as in Example 1 except that a part of P2 O5 was replaced by the substance identified in Table 4.
The crystallized glass thereby obtained had the same properties as Sample H in Example 4, and had the gloss, color and color tone resembling natural teeth.
              TABLE 4                                                     
______________________________________                                    
Sample No.                                                                
         Substance                                                        
______________________________________                                    
L        RuO.sub.2 powder corresponding to 0.08% by                       
         weight of Ru                                                     
M        Rh.sub.2 O.sub.3 powder corresponding to 0.02% by                
         weight of Rh                                                     
N        PdO powder corresponding to 0.04% by                             
         weight of Pd                                                     
S        Mixture of Ru(OH).sub.3 powder corresponding to                  
         0.05% by weight of Ru and PdCl.sub.3 powder                      
         corresponding to 0.02% by weight of Pd                           
T        Mixture of RuO.sub.2 powder corresponding to                     
         0.05% by weight of Ru, Rh.sub.2 O.sub.3 powder                   
         corresponding to 0.01% by weight of Rh and                       
         PdO powder corresponding to 0.01% by weight                      
         of Pd                                                            
______________________________________                                    
As is evident from the Examples, the Comparative Examples, Tables 1 and 3 and FIG. 1, the calcium phosphate type crystallized glass obtained by crystallizing calcium phosphate type crystallizable glass containing from 0.5 to 5 mol % of Al2 O3 and having an atomic ratio of Ca/P of from 0.35 to 0.49 has high strength and excellent water resistance with high strength after the soaking test in water, as compared with the calcium phosphate crystallized glass containing from 0.5 to 5 mol % of Al2 O3 and having an atomic ratio of Ca/P of from 0.5 to 1.7. Besides, the crystallized glass obtained by the present invention has translucency resembling natural teeth, and its color is milky white or close to the color of natural teeth. Furthermore, the molten glass can readily be molded into a product having a complicated shape by casting method such as a lost-wax method. Thus, the calcium phosphate type crystallizable glass of the present invention is most suitable for artificial dental materials such as artificial teeth, crowns, inlays or bridges.

Claims (3)

We claim:
1. Calcium phosphate crystallized glass for dental materials consisting essentially of from 41 to 49.5 mol % of CaO, from 50 to 58.5 mol % of P2 O5 and from 0.5 and 5 mol % of Al2 O3, and which has an atomic ratio of calcium to phosphorus (Ca/P) of from 0.35 to 0.45.
2. The calcium phosphate crystallized glass according to claim 1, wherein the calcium phosphate crystallized glass is composed essentially of from 42 to 44 mol % of CaO, from 53 to 55 mol % of P2 O5 and from 2 to 4 mol % of Al2 O3, and has an atomic ratio of calcium to phosphorus (Ca/P) within a range of from 0.38 to 0.42.
3. The calcium phosphate crystallized glass according to claim 1, which further contains from 0.001 to 1 mol % of at least one element selected from the group consisting of Ru, Rh and Pd.
US06/775,355 1984-09-14 1985-09-12 Calcium phosphate type crystallizable glass Expired - Fee Related US4617279A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59191437A JPS6172652A (en) 1984-09-14 1984-09-14 Calcium phosphate-based crystalline glass for dental material
JP59-191437 1984-09-14

Publications (1)

Publication Number Publication Date
US4617279A true US4617279A (en) 1986-10-14

Family

ID=16274602

Family Applications (1)

Application Number Title Priority Date Filing Date
US06/775,355 Expired - Fee Related US4617279A (en) 1984-09-14 1985-09-12 Calcium phosphate type crystallizable glass

Country Status (4)

Country Link
US (1) US4617279A (en)
EP (1) EP0175265B1 (en)
JP (1) JPS6172652A (en)
DE (1) DE3578546D1 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693748A (en) * 1986-09-29 1987-09-15 Asahi Glass Company Ltd. Composition for staining material
US4781744A (en) * 1985-10-11 1988-11-01 Asahi Glass Company Ltd. Molding method
US4829026A (en) * 1988-05-06 1989-05-09 Kuraray Co., Ltd. Glass ceramics
US5077079A (en) * 1990-02-09 1991-12-31 Agency Of Industrial Science & Technology Method for formation of calcium phosphate compound coating on surface of ceramic article
US5236495A (en) * 1990-08-21 1993-08-17 Asahi Glass Company Ltd. Calcium phosphate type glass-ceramic
US5447924A (en) * 1990-08-15 1995-09-05 Leo Pharmaceutical Products Ltd. Vitamin D analogues
US5565462A (en) * 1991-09-02 1996-10-15 Teva Pharmaceutical Industries, Ltd. Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative
US5663157A (en) * 1992-06-30 1997-09-02 Schering Aktiengesellschaft 22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents
US5951509A (en) * 1996-11-22 1999-09-14 Therakos, Inc. Blood product irradiation device incorporating agitation
US6247986B1 (en) 1998-12-23 2001-06-19 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
US6306926B1 (en) 1998-10-07 2001-10-23 3M Innovative Properties Company Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same
US6306948B1 (en) 1999-10-26 2001-10-23 3M Innovative Properties Company Molding composition containing a debinding catalyst for making ceramic microstructures
US6352763B1 (en) 1998-12-23 2002-03-05 3M Innovative Properties Company Curable slurry for forming ceramic microstructures on a substrate using a mold
US20030100192A1 (en) * 2001-10-09 2003-05-29 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold and articles formed by the method
US20030098528A1 (en) * 2001-10-09 2003-05-29 3M Innovative Properties Company Method for forming microstructures on a substrate using a mold
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
EP1228744A3 (en) * 2001-02-06 2004-04-21 Tomy Incorporated Orthodontic appliance
US6821178B2 (en) 2000-06-08 2004-11-23 3M Innovative Properties Company Method of producing barrier ribs for plasma display panel substrates
US20050218812A1 (en) * 2002-06-04 2005-10-06 Van Den Brakel Ronald A Low-pressure mercury vapor discharge lamp and compact fluorescent lamp
US20070243991A1 (en) * 2006-04-18 2007-10-18 Brow Richard K Alkaline resistant phosphate glasses and method of preparation and use thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61186247A (en) * 1985-02-13 1986-08-19 Kyushu Refract Co Ltd Crystallized cao-al2o3-p2o5 glass
GB8612387D0 (en) * 1986-05-21 1986-07-16 Univ Sheffield Glass ceramics
JP2621249B2 (en) * 1987-11-13 1997-06-18 ライオン株式会社 Dental material and method for improving adhesion of dental material to adhesive resin cement

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1570202A (en) * 1924-02-26 1926-01-19 Buck Eugene Charles Vitreous composition and articles made therefrom
US3300670A (en) * 1962-02-28 1967-01-24 Table xiv
US3981736A (en) * 1973-05-23 1976-09-21 Ernst Leitz G.M.B.H. Biocompatible glass ceramic material
US4026714A (en) * 1975-09-19 1977-05-31 Imperial Chemical Industries Limited Phosphate glass compositions
JPS5511625A (en) * 1978-07-12 1980-01-26 Hitachi Ltd Multiplying device
US4366253A (en) * 1979-08-10 1982-12-28 Fuji Photo Film Co., Ltd. Phosphate glass compositions, and glass-ceramic materials, and methods of making the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2073732B (en) * 1980-04-03 1985-01-09 Standard Telephones Cables Ltd Water-soluble calcium phosphate glasses and anticorrosive paints incorporating them
JPS5777038A (en) * 1980-10-28 1982-05-14 Asahi Glass Co Ltd Manufacture of crystallized glass from phosphate glass

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1570202A (en) * 1924-02-26 1926-01-19 Buck Eugene Charles Vitreous composition and articles made therefrom
US3300670A (en) * 1962-02-28 1967-01-24 Table xiv
US3981736A (en) * 1973-05-23 1976-09-21 Ernst Leitz G.M.B.H. Biocompatible glass ceramic material
US4026714A (en) * 1975-09-19 1977-05-31 Imperial Chemical Industries Limited Phosphate glass compositions
JPS5511625A (en) * 1978-07-12 1980-01-26 Hitachi Ltd Multiplying device
US4366253A (en) * 1979-08-10 1982-12-28 Fuji Photo Film Co., Ltd. Phosphate glass compositions, and glass-ceramic materials, and methods of making the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Kihara, Seij et al.; Calcium Phosphate Glass Ceramic Crown Prepared by Lost Wax Technique , Communications of the American Ceramic Society, pp. C100 101, Jun. 1984. *
Kihara, Seije et al.; "Calcium Phosphate Glass-Ceramic Crown Prepared by Lost-Wax Technique", Communications of the American Ceramic Society, pp. C100-101, Jun. 1984.
Wihsmann et al.; "Bioaktive Implantate auf der Basis von Vitrokerammaterialien", Wiss. Ztschr. Friedrich-Schiller Univ. Jena, Math.-Naturwiss. R., 32, Jg (1983), H. 2/3, pp. 553-569.
Wihsmann et al.; Bioaktive Implantate auf der Basis von Vitrokerammaterialien , Wiss. Ztschr. Friedrich Schiller Univ. Jena, Math. Naturwiss. R., 32, Jg (1983), H. 2/3, pp. 553 569. *

Cited By (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4781744A (en) * 1985-10-11 1988-11-01 Asahi Glass Company Ltd. Molding method
US4693748A (en) * 1986-09-29 1987-09-15 Asahi Glass Company Ltd. Composition for staining material
US4829026A (en) * 1988-05-06 1989-05-09 Kuraray Co., Ltd. Glass ceramics
US5077079A (en) * 1990-02-09 1991-12-31 Agency Of Industrial Science & Technology Method for formation of calcium phosphate compound coating on surface of ceramic article
US5447924A (en) * 1990-08-15 1995-09-05 Leo Pharmaceutical Products Ltd. Vitamin D analogues
US5236495A (en) * 1990-08-21 1993-08-17 Asahi Glass Company Ltd. Calcium phosphate type glass-ceramic
US20040009958A1 (en) * 1991-01-08 2004-01-15 Bone Care International, Inc. Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
US5565462A (en) * 1991-09-02 1996-10-15 Teva Pharmaceutical Industries, Ltd. Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative
US5663157A (en) * 1992-06-30 1997-09-02 Schering Aktiengesellschaft 22-en-25-oxa derivatives in the vitamin D series, process for their production, pharmaceutical preparations containing these derivatives as well as their use as pharmaceutical agents
US5951509A (en) * 1996-11-22 1999-09-14 Therakos, Inc. Blood product irradiation device incorporating agitation
US6306926B1 (en) 1998-10-07 2001-10-23 3M Innovative Properties Company Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same
US7030049B2 (en) 1998-10-07 2006-04-18 3M Innovative Properties Company Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same
US20060052232A1 (en) * 1998-10-07 2006-03-09 3M Innovative Properties Company Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same
US20030158289A1 (en) * 1998-10-07 2003-08-21 3M Innovative Properties Company Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same
US6465541B2 (en) 1998-10-07 2002-10-15 3M Innovative Properties Company Radiopaque cationically polymerizable compositions comprising a radiopacifying filler, and method for polymerizing same
US6802754B2 (en) 1998-12-23 2004-10-12 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
USRE40967E1 (en) * 1998-12-23 2009-11-10 3M Innovative Properties Company Curable slurry for forming ceramic microstructures on a substrate using a mold
US6325610B2 (en) 1998-12-23 2001-12-04 3M Innovative Properties Company Apparatus for precise molding and alignment of structures on a substrate using a stretchable mold
US6984935B2 (en) 1998-12-23 2006-01-10 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
US6616887B2 (en) 1998-12-23 2003-09-09 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
US6247986B1 (en) 1998-12-23 2001-06-19 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
US6352763B1 (en) 1998-12-23 2002-03-05 3M Innovative Properties Company Curable slurry for forming ceramic microstructures on a substrate using a mold
US20040058614A1 (en) * 1998-12-23 2004-03-25 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
US6713526B2 (en) 1998-12-23 2004-03-30 3M Innovative Properties Company Curable slurry for forming ceramic microstructures on a substrate using a mold
US20050029942A1 (en) * 1998-12-23 2005-02-10 3M Innovative Properties Company Method for precise molding and alignment of structures on a substrate using a stretchable mold
US6699927B2 (en) 1999-10-26 2004-03-02 3M Innovative Properties Company Molding composition containing a debinding catalyst for making ceramic microstructures
US6306948B1 (en) 1999-10-26 2001-10-23 3M Innovative Properties Company Molding composition containing a debinding catalyst for making ceramic microstructures
US20020007000A1 (en) * 1999-10-26 2002-01-17 3M Innovative Properties Company Molding composition containing a debinding catalyst for making ceramic microstructures
US6821178B2 (en) 2000-06-08 2004-11-23 3M Innovative Properties Company Method of producing barrier ribs for plasma display panel substrates
EP1228744A3 (en) * 2001-02-06 2004-04-21 Tomy Incorporated Orthodontic appliance
US20060087055A1 (en) * 2001-10-09 2006-04-27 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold and articles formed by the method
US20060066007A1 (en) * 2001-10-09 2006-03-30 3M Innovative Properties Company Methods for forming microstructures on a substrate using a mold
US20030098528A1 (en) * 2001-10-09 2003-05-29 3M Innovative Properties Company Method for forming microstructures on a substrate using a mold
US7033534B2 (en) 2001-10-09 2006-04-25 3M Innovative Properties Company Method for forming microstructures on a substrate using a mold
US7176492B2 (en) 2001-10-09 2007-02-13 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold and articles formed by the method
US7429345B2 (en) 2001-10-09 2008-09-30 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold
US20030100192A1 (en) * 2001-10-09 2003-05-29 3M Innovative Properties Company Method for forming ceramic microstructures on a substrate using a mold and articles formed by the method
US20050218812A1 (en) * 2002-06-04 2005-10-06 Van Den Brakel Ronald A Low-pressure mercury vapor discharge lamp and compact fluorescent lamp
US20070243991A1 (en) * 2006-04-18 2007-10-18 Brow Richard K Alkaline resistant phosphate glasses and method of preparation and use thereof
WO2007121071A2 (en) * 2006-04-18 2007-10-25 Mo-Sci Corporation Alkaline resistant phosphate glasses and method of preparation and use thereof
WO2007121071A3 (en) * 2006-04-18 2009-04-16 Mo Sci Corp Alkaline resistant phosphate glasses and method of preparation and use thereof
US7651966B2 (en) 2006-04-18 2010-01-26 Mo-Sci Corporation Alkaline resistant phosphate glasses and method of preparation and use thereof

Also Published As

Publication number Publication date
DE3578546D1 (en) 1990-08-09
JPS6172652A (en) 1986-04-14
EP0175265A2 (en) 1986-03-26
JPH0469094B2 (en) 1992-11-05
EP0175265B1 (en) 1990-07-04
EP0175265A3 (en) 1987-01-14

Similar Documents

Publication Publication Date Title
US4617279A (en) Calcium phosphate type crystallizable glass
US5236495A (en) Calcium phosphate type glass-ceramic
GB2153342A (en) Method for strengthening dental restorative material
JPS6028911A (en) Crystallized calcium phosphate glass dental material having excellent appearance
US4799887A (en) Glass ceramic dental crown and method of manufacturing the same
US4943541A (en) Glass ceramics
US4781744A (en) Molding method
US4693748A (en) Composition for staining material
JPS63176335A (en) Crystallized glass and production thereof
WO1988001256A1 (en) Glass ceramics composition
RU2144814C1 (en) Glassceramic material for manufacturing dentures
JPS60221342A (en) High-strength calcium phosphate crystallized glass
JPH0424300B2 (en)
JPS6171044A (en) Production of calcium phosphate type crystallized glass dental molded body
JPH0723234B2 (en) Colored calcium phosphate glass
JPH0421621B2 (en)
JPS638235A (en) Calcium phosphate glass
JPS60204636A (en) Production of calcium phosphate based dental material
JPS60211063A (en) Preparation of dental material comprising calcium phosphate having low melting point
JPS60131835A (en) Manufacture of calcium phosphate cast body
JPH0532517A (en) Colored calcium phosphate-based glass and dental material obtained by crystallizing the same
JPH0476939B2 (en)
JPS6177643A (en) Colored borosilicate crystallized glass
JPS6163540A (en) Preparation of crystallized calcium phosphate glass for dental material
JPS63260839A (en) Crystallized glass for dental material

Legal Events

Date Code Title Description
AS Assignment

Owner name: ASAHI GLASS COMPANY, LTD., NO. 1-2, MARUNOUCHI 2-C

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNORS:MANABE, TSUNEO;KOBAYASHI, SHIGEYOSHI;KIJIMUTA, HITOSHI;REEL/FRAME:004569/0458

Effective date: 19850903

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FPAY Fee payment

Year of fee payment: 8

REMI Maintenance fee reminder mailed
LAPS Lapse for failure to pay maintenance fees
FP Lapsed due to failure to pay maintenance fee

Effective date: 19981014

STCH Information on status: patent discontinuation

Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362